Highlights: Phase 1 open-label trial enrolled six fetuses with myelomeningocele No stem cell-related infections,

NeuroScientific Biopharmaceuticals has begun transferring production of its StemSmart stem cell therapy to Q-Gen in Brisbane, a key step towards phase...

NeuroScientific Biopharmaceuticals has begun transferring production of its StemSmart stem cell therapy to Q-Gen in Brisbane, a key step towards phase...

Two induced pluripotent stem cell therapies receive conditional approval in Japan after small clinical trials showed symptom improvement in...

Two induced pluripotent stem cell therapies receive conditional approval in Japan after small clinical trials showed symptom improvement in...

NeuroScientific Biopharmaceuticals has begun transferring the production of stem cells for its StemSmart therapy to Q-Gen in Brisbane, ahead of...

NeuroScientific Biopharmaceuticals has begun transferring the production of stem cells for its StemSmart therapy to Q-Gen in Brisbane, ahead of...

The groundbreaking stem cell transplant programme is officially expanding, but experts warn its future growth depends entirely on one factor: the...

Highlights: Japan approves world's first iPSC-based therapies for Parkinson's and severe heart failure under cond